Legato Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,006
Closed -$735K 773
2026
Q1
$735K Sell
3,006
-8,167
-73% -$1.9M 0.07% 385
2025
Q4
$2.31M Sell
11,173
-9,548
-46% -$1.89M 0.2% 143
2025
Q3
$3.84M Sell
20,721
-1,167
-5% -$200K 0.42% 50
2025
Q2
$3.34M Hold
21,888
0.4% 53
2025
Q1
$3.63M Hold
21,888
0.49% 34
2024
Q4
$3.17M Sell
21,888
-3,565
-14% -$552K 0.41% 38
2024
Q3
$4.12M Hold
25,453
0.51% 27
2024
Q2
$3.72M Sell
25,453
-5,790
-19% -$861K 0.5% 29
2024
Q1
$4.94M Buy
31,243
+2,181
+8% +$347K 0.6% 26
2023
Q4
$4.56M Hold
29,062
0.59% 28
2023
Q3
$4.53M Buy
29,062
+2,254
+8% +$372K 0.66% 21
2023
Q2
$4.44M Buy
26,808
+6,993
+35% +$1.13M 0.6% 22
2023
Q1
$3.07M Hold
19,815
0.56% 27
2022
Q4
$3.5M Buy
+19,815
New +$3.42M 0.67% 17
2021
Q3
Sell
-14,061
Closed -$2.32M 259
2021
Q2
$2.32M Buy
+14,061
New +$2.33M 0.33% 87

Other funds holding JNJ

Legato Capital Management's JNJ Position: Q2 2026 in Review

Legato Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 3,006 shares — an estimated $735K sold.

Legato Capital Management first reported a position in JNJ in Q2 2021 and held it in 15 quarters. The position peaked at $4.94M in Q1 2024. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Legato Capital Management reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Legato Capital Management sold 3,006 Johnson & Johnson shares in Q2 2026, an estimated $735K.
  • Legato Capital Management first reported a position in Johnson & Johnson in Q2 2021 and held it in 15 quarters.
  • Legato Capital Management's Johnson & Johnson position peaked at $4.94M in Q1 2024.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.